Table 2.

Effect of PC, ω-3 fatty acids and ATOR administration on inflammation, and calcification markers Of DH rats

Parameters	NG	DHC	ATOR	ω3	PC
TNF-α (pg/ml)	31 ± 1.9	120.4 ± 3.8♯	78.3 ± 1.5*	62.9 ± 0.4*c	49.83 ± 0.7*c++
CRP (mg/l)	0.3 ± 0.03	3.1 ± 0.14♯	0.65 ± 0.04*	0.5 ± 0.07*	0.3750 ± 0.05*
ALP (U/l)	125 ± 2.78	377.8 ± 47.7♯	150.7 ± 0.44*	162.8 ± 0.4*	140.3 ± 0.36*
VIT.D (ng/ml)	46.23 ± 0.84	12.77 ± 1.5♯	28.3 ± 0.7*	22.7 ± 1.6*c	36.08 ± 1.9*c+ +
PTH (pg/ml)	22.92 ± 2.2	74.92 ± 1.4♯	37 ± 1.09*	30.18 ± 0.9*c	25.62 ± 0.9*c++

All data are presented as the mean ± SD, n = 6.

^#p < 0.001: NG vs. DHC; *p < 0.001: DHC vs. treated groups; ^cp < 0.001: ATOR vs. ω-3, PC;⁺⁺p < 0.001: ω-3 vs. PC.